Bixiang Zhang
About
In The Last Decade
Bixiang Zhang
202 papers receiving 7.2k citations
Hit Papers
Peers
Comparison fields: 5 of 169
- Molecular Biology 3.3k
- Cancer Research 1.7k
- Oncology 1.7k
- Hepatology 939
- Immunology 934
Countries citing papers authored by Bixiang Zhang
This map shows the geographic impact of Bixiang Zhang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bixiang Zhang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bixiang Zhang more than expected).
Fields of papers citing papers by Bixiang Zhang
This network shows the impact of papers produced by Bixiang Zhang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bixiang Zhang. The network helps show where Bixiang Zhang may publish in the future.
Co-authorship network of co-authors of Bixiang Zhang
This figure shows the co-authorship network connecting the top 25 collaborators of Bixiang Zhang. A scholar is included among the top collaborators of Bixiang Zhang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bixiang Zhang. Bixiang Zhang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 2 | |
| 2 | 23 | |
| 3 | 19 | |
| 4 | 1 | |
| 5 | 63 | |
| 6 | 70 | |
| 7 | FGF19/FGFR4-mediated elevation of ETV4 facilitates hepatocellular carcinoma metastasis by upregulating PD-L1 and CCL2 breakdown → | 112 |
| 8 | 10 | |
| 9 | 4 | |
| 10 | 7 | |
| 11 | Reversing insufficient photothermal therapy-induced tumor relapse and metastasis by regulating cancer-associated fibroblasts breakdown → | 200 |
| 12 | Boosting anti-PD-1 therapy with metformin-loaded macrophage-derived microparticles breakdown → | 271 |
| 13 | 20 | |
| 14 | 11 | |
| 15 | 7 | |
| 16 | 32 | |
| 17 | 3 | |
| 18 | [The role of extracellular signal-regulated kinase/mitogen-activated protein kinase pathway in multidrug resistance of hepatocellular carcinoma]. | 7 |
| 19 | 3 | |
| 20 | [Hypoxia-inducible factor-1 alpha dependent expression and significance of the related multidrug resistance genes induced by hypoxia in human hepatocarcinoma cell]. | 5 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.